Strathprints logo
Strathprints Home | Open Access | Browse | Search | User area | Copyright | Help | Library Home | SUPrimo

Inhibition of p38 MAPK reverses hypoxia-induced pulmonary artery endothelial dysfunction

Weerackody, Roshan P. and Welsh, David J. and Wadsworth, Roger M. and Peacock, Andrew J. (2009) Inhibition of p38 MAPK reverses hypoxia-induced pulmonary artery endothelial dysfunction. American Journal of Physiology - Heart and Circulatory Physiology, 296. H1312-H1320. ISSN 0363-6135

Full text not available in this repository. (Request a copy from the Strathclyde author)

Abstract

Hypoxia-induced endothelial dysfunction plays a crucial role in the pathogenesis of hypoxic pulmonary hypertension. p38 MAPK expression is increased in the pulmonary artery following hypoxic exposure. Recent evidence suggests that increased p38 MAPK activity is associated with endothelial dysfunction. However, the role of p38 MAPK activation in pulmonary artery endothelial dysfunction is not known. Sprague-Dawley rats were exposed to 2 wk hypobaric hypoxia, which resulted in the development of pulmonary hypertension and vascular remodeling. Endothelium-dependent relaxation of intrapulmonary vessels from hypoxic animals was impaired due to a reduced nitric oxide (NO) generation. This was despite increased endothelial NO synthase immunostaining and protein expression. Hypoxia exposure increased superoxide generation and p38 MAPK expression. The inhibition of p38 MAPK restored endothelium-dependent relaxation, increased bioavailable NO, and reduced superoxide production. In conclusion, the pharmacological inhibition of p38 MAPK was effective in increasing NO generation, reducing superoxide burden, and restoring hypoxia-induced endothelial dysfunction in rats with hypoxia-induced pulmonary hypertension. p38 MAPK may be a novel target for the treatment of pulmonary hypertension.

Item type: Article
ID code: 13159
Keywords: ihypoxia, pulmonary artery endothelial dysfunction, cardiology, heart, circulatory system, Therapeutics. Pharmacology, Pharmacy and materia medica, Microbiology, Physiology, Cardiology and Cardiovascular Medicine, Physiology (medical)
Subjects: Medicine > Therapeutics. Pharmacology
Medicine > Pharmacy and materia medica
Science > Microbiology
Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Related URLs:
    Depositing user: Ms Ann Barker-Myles
    Date Deposited: 06 Oct 2009 12:43
    Last modified: 04 Sep 2014 23:30
    URI: http://strathprints.strath.ac.uk/id/eprint/13159

    Actions (login required)

    View Item